abstract |
The present disclosure relates to (4-4′-diimidazolyl) biphenyls, compositions and methods for treating hepatitis C virus (HCV) infection. Also disclosed are pharmaceutical compositions containing such compounds and methods of using these compounds in the treatment of HCV infection. |